Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Braincells13on Jan 03, 2018 7:39pm
121 Views
Post# 27275637

RE:RE:RE:Quick and Dirty Sanity Check

RE:RE:RE:Quick and Dirty Sanity Check
Aditional things to note:

-PE of 20 is aggressive once they reach their peek; when (or if) they get there it should shrink a lot.

-How many companies will sell weed? A lot. Using total capacity to estimate sales is a huge flaw. For instance, industrial capacity utilization of tobacco companies in Canada is 55-65% (see https://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/econ91-eng.htm ).

-In addition, this would exclude any other additional taxes (for example, for cigarette & gaz on top of HST there are additional taxes). I'd personnaly use 10% as a best estimate. Therefore, sale price (pre-tax) will be a maximum of $8. Remove from that the margin of the seller (for instance LCBO as a 50%; maybe they would be fine with a 30% margin for marijuana products?) selling price would be max $5.60.

-Altough production cost could be below $1 per gram, there will be additional costs, such as packaging, shipping, handling, etc. that will need to be factored in COGS.

When I do a quick math I obtain a value that is much lower than the current market cap.


Bullboard Posts